There will be the ignorant and easily spooked mums and dads who will sell following a death during the trials, no doubt. But the grownups in the room (Instos and BP) look deeper, at the actual science. They know MPL is not a cure for MND, but rather a treatment that 'only' extends life expectancy by 3-5 years! Three to five years increased life expectancy!
When Instos & BP looks at the minimal life expectancy offered by drugs such as Riluzole (2-3 months) and Relyvrio (now pulled from market as so useless with no extended life expectancy), yet the hundreds of millions these drugs were pulling in, I don't think they're going to be spooked by a few patients passing. This is an inevitability, but the majority of patients surviving is what's more important! Most patients will take the chance they will get the extended expectancy!
- Forums
- ASX - By Stock
- PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
There will be the ignorant and easily spooked mums and dads who...
-
-
- There are more pages in this discussion • 66 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
|
|||||
Last
20.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $89.00M |
Open | High | Low | Value | Volume |
20.0¢ | 20.0¢ | 19.3¢ | $112.4K | 570.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 71364 | 19.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.0¢ | 457262 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 71364 | 0.195 |
19 | 583155 | 0.190 |
28 | 1152549 | 0.185 |
19 | 993658 | 0.180 |
10 | 743068 | 0.175 |
Price($) | Vol. | No. |
---|---|---|
0.200 | 457262 | 6 |
0.205 | 202546 | 7 |
0.215 | 206000 | 4 |
0.220 | 109118 | 1 |
0.225 | 62500 | 1 |
Last trade - 15.59pm 05/07/2024 (20 minute delay) ? |
Featured News
PAA (ASX) Chart |